Results 11 to 20 of about 15,139,370 (299)

Correction: Metabolic syndrome and immune-related adverse events [PDF]

open access: yesCancer Immunology, Immunotherapy
Katherine Lei   +12 more
doaj   +2 more sources

IL12/23 Blockade with Ustekinumab as a Treatment for Immune-Related Cutaneous Adverse Events

open access: yesPharmaceuticals, 2023
Background: Immune-related cutaneous adverse events (ircAEs) are frequent and may reduce quality of life and consistent dosing. IL12/23 has been implicated in psoriasis, which is reminiscent of the psoriasiform/lichenoid ircAE phenotype.
Stephanie L. Gu   +6 more
doaj   +1 more source

Rare immune-related adverse events in patients with melanoma: incidence, spectrum, and clinical presentations

open access: yesOncoImmunology, 2023
Immune-related adverse events (irAEs) are side effects of immune checkpoint inhibitor therapy (ICI). While common irAEs have been well characterized, there are more limited data on rare immune related adverse events (RirAEs) due to low incidence. Lack of
Benjamin C. Park   +13 more
doaj   +1 more source

Treatment-Related Serious Adverse Events of Immune Checkpoint Inhibitors in Clinical Trials: A Systematic Review

open access: yesFrontiers in Oncology, 2021
BackgroundImmune Checkpoint Inhibitors (ICI) have been progressively used in cancer treatment and produced unique toxicity profiles. This systematic review aims to comprehend the patterns and occurrence of treatment-related adverse events (trAEs) based ...
Tao Ouyang   +19 more
doaj   +1 more source

The management of rheumatic immune related adverse events. [PDF]

open access: yesBest Pract Res Clin Rheumatol
Immune checkpoint inhibitors (ICI) used for the treatment of cancer can cause immune related adverse events (irAEs) when immune activation affects non-tumor tissues. Rheumatologists care for patients with a variety of rheumatic irAEs; these included inflammatory arthritis (ICI-IA), polymyalgia rheumatica (ICI-PMR), and myositis (ICI-myositis) among ...
Reid P, Singh N, Braaten T, Cappelli LC.
europepmc   +4 more sources

Rheumatological Adverse Events Following Immunotherapy for Cancer

open access: yesMedicina, 2022
Background and Objectives: The occurrence of rheumatological side effects in a patient after receiving immunotherapy for cancer is becoming increasingly common. Oncologists often fail to diagnose and refer affected patients to rheumatologists. This paper
Ioana Cretu   +6 more
doaj   +1 more source

Immune-Related Adverse Events: Pneumonitis [PDF]

open access: yes, 2020
Checkpoint inhibitors are part of the family of immunotherapies and are increasingly being used in a wide variety of cancers. Immune-related adverse events pose a major challenge in the treatment of cancer patients. Pneumonitis is a rare immune-related adverse event that presents in distinct patterns.
Zhong, Linda   +3 more
openaire   +2 more sources

Editorial: Immune-related adverse Events (irAEs) of biopharmaceuticals

open access: yesFrontiers in Allergy, 2023
Alexander Batista-Duharte   +2 more
doaj   +3 more sources

Editorial: Immune-Related Adverse Events for Patients With Lung Cancer [PDF]

open access: yes, 2022
Editorial on the Research Topic Immune-Related Adverse Events for Patients with Lung ...
Frey, Benjamin   +13 more
core   +1 more source

Immune checkpoint inhibitors⁃related nervous system adverse events

open access: yesChinese Journal of Contemporary Neurology and Neurosurgery, 2022
Immune checkpoint inhibitors (ICIs) have been widely used in tumor treatment. Immune⁃related adverse events (irAEs) are common in skin, endocrine, gastrointestinal tract, liver and cardiovascular system symptoms.
WANG Ze⁃yi, LIU Guang⁃zhi
doaj   +1 more source

Home - About - Disclaimer - Privacy